Understanding the Market | TRANSTHERA-B opened over 6% higher after reaching a project cooperation agreement with Neurocrine to further develop NLRP3-related technologies
I'm PortAI, I can summarize articles.
TRANSTHERA-B's stock price opened more than 6% higher, and as of the time of writing, it has risen 6.58% to HKD 195.9, with a trading volume of HKD 6.5627 million. The company has signed a patent transfer and research cooperation agreement with Neurocrine Biosciences to develop NLRP3 inhibitors, with a total potential value of USD 881.5 million, covering exclusive development rights and related research cooperation outside of Greater China
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments